Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Mangoceuticals, Inc./ 425

Rule 425 Communication · 425

Mangoceuticals, Inc.

MGRXNASDAQEQUITYCurrent

Rule 425 Communication

Filed Aug 4, 2026Accepted Aug 4, 2026, 4:30 PM EDTCIK 1938046Accession 0001493152-26-036008
View company →Permanent SEC source ↗
Share

Company context

Current securities

MGRXNASDAQ · EQUITY · Current

Recent company filings

  1. Termination of a Material Definitive AgreementAug 21, 2026
  2. 10-Q filingAug 13, 2026
  3. 425 filingAug 13, 2026
  4. 425 filingAug 6, 2026
  5. Other EventsAug 4, 2026

As-filed source

Primary evidence
As filedOpen full document ↗